FDA product code DXX: System, Catheter Control, Steerable
DXX is the FDA product code for system, catheter control, steerable. It is a Class II device, regulated under 21 CFR 870.1290 and reviewed by the Cardiovascular panel. FDA has cleared 34 510(k) submissions under DXX, 4 in the last five years, from 8 different applicants. The average 510(k) review took 162 days (median 125); 116 days on average over the last three years. FDA has posted 4 recalls for DXX devices.
Classification
| Field | Value |
|---|---|
| Device name | System, Catheter Control, Steerable |
| Device class | Class II |
| Regulation | 21 CFR 870.1290 |
| Review panel | CV — Cardiovascular |
| Medical specialty | Cardiovascular |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for DXX
| Year | Clearances | Avg. review days |
|---|---|---|
| 2018 | 3 | 76 |
| 2020 | 1 | 122 |
| 2022 | 1 | 69 |
| 2025 | 2 | 208 |
| 2026 | 1 | 24 |
Compare with all 510(k) review times · Search every DXX clearance
Top DXX applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Stereotaxis, Inc. | 9 | 2026-08-27 |
| Corindus, Inc. | 9 | 2022-07-27 |
| Hansen Medical, Inc. | 9 | 2015-07-23 |
| Catheter Robotics, Inc. | 2 | 2012-11-20 |
| Catheter Research C/O Burditt, Bowles & Radzius | 2 | 1993-05-26 |
3 more applicants have DXX clearances. See the full list in Caduvo.
Most recent DXX clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K262744 | Stereotaxis, Inc. | GenesisX RMN | 2026-08-27 | 24 |
| K251792 | Stereotaxis, Inc. | Stereotaxis GenesisX RMN with Navigant Workstation (NWS) | 2025-11-06 | 148 |
| K243789 | Microbot Medical , Ltd. | LIBERTY Endovascular Robotic System (LIBERTYOS) | 2025-09-04 | 269 |
| K221464 | Corindus, Inc. | CorPath GRX System | 2022-07-27 | 69 |
| K202275 | Corindus, Inc. | CorPath GRX System | 2020-12-11 | 122 |
Recalls for DXX devices
4 product recalls in 4 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2016-03-25.
Frequently asked questions
What is FDA product code DXX?
DXX is the FDA product code for system, catheter control, steerable. It is a Class II device, regulated under 21 CFR 870.1290 and reviewed by the Cardiovascular panel.
What device class is DXX?
Class II, regulation 21 CFR 870.1290. Typical premarket route: 510(k).
How long does a 510(k) take for product code DXX?
Across 34 cleared submissions the average was 162 days from receipt to decision (median 125).
Which companies have the most DXX clearances?
Stereotaxis, Inc. (9); Corindus, Inc. (9); Hansen Medical, Inc. (9); Catheter Robotics, Inc. (2); Catheter Research C/O Burditt, Bowles & Radzius (2).
Have DXX devices been recalled?
Yes: 4 product recalls across 4 recall events; the most recent began 2016-03-25.
Next steps
- Run an FDA pathway report with predicate devices for product code DXX
- Run a recall and safety report across every DXX manufacturer
- Watch product code DXX for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times